2,362
Views
0
CrossRef citations to date
0
Altmetric
Zoster

Knowledge, attitude, and practice toward herpes zoster (HZ) and HZ vaccination: Concept elicitation findings from a multi-country study in the Asia Pacific

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2317446 | Received 06 Nov 2023, Accepted 07 Feb 2024, Published online: 04 Mar 2024

References

  • Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274–9. doi:10.4065/84.3.274.
  • Chen LK, Arai H, Chen LY, Chou MY, Djauzi S, Dong B, Kojima T, Kwon KT, Leong HN, Leung EM, et al. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis. 2017;17(1):213. doi:10.1186/s12879-017-2198-y.
  • Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. Disease burden of herpes zoster in Korea. J Clin Virol. 2010;47(4):325–9. doi:10.1016/j.jcv.2010.01.003.
  • Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vacc. 2015;3(4):109–20. doi:10.1177/2051013615599151.
  • van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother. 2021;17(6):1714–32. doi:10.1080/21645515.2020.1847582.
  • Curran D, Schmidt-Ott R, Schutter U, Simon J, Anastassopoulou A, Matthews S. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above. BMC Infect Dis. 2018;18(1):496. doi:10.1186/s12879-018-3395-z.
  • Gater A, Uhart M, McCool R, Préaud E. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health. 2015;15:193. doi:10.1186/s12889-015-1514-y.
  • Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, Hashemi M, Rampakakis E, Kawai K, White R, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis. 2014;20:23–30. doi:10.1016/j.ijid.2013.11.018.
  • Weinke T, Edte A, Schmitt S, Lukas K. Impact of herpes zoster and post-herpetic neuralgia on patients’ quality of life: a patient-reported outcomes survey. Z Gesundh Wiss. 2010;18(4):367–74. doi:10.1007/s10389-010-0323-0.
  • Imafuku S, Matsuki T, Mizukami A, Goto Y, de Souza S, Jégou C, Bianco V, Rosillon D, Ito C, Curran D, et al. Burden of herpes zoster in the Japanese population with immunocompromised/chronic disease conditions: results from a cohort study claims database from 2005–2014. Dermatol Ther (Heidelb). 2019;9(1):117–33. doi:10.1007/s13555-018-0268-8.
  • Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014;29(12):1706–1710. doi:10.3346/jkms.2014.29.12.1706.
  • Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, Merler S. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study. BMC Med. 2018;16(1):117. doi:10.1186/s12916-018-1094-7.
  • Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, et al. A systematic literature review to assess the burden of herpes zoster disease in China. Expert Rev Anti Infect Ther. 2021;19(2):165–79. doi:10.1080/14787210.2020.1792290.
  • Dooling KG, Patel M, Lee GM, Moore K, Belongia EA. Harpaz R. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. Morb Mortal Wkly Rep. 2018;67(3):103–8. doi:10.15585/mmwr.mm6703a5.
  • Centers for Disease Control and Prevention. Clinical considerations for use of recombinant zoster vaccine (RZV, Shingrix) in immunocompromised adults aged ≥19 years. Centers For Disease Control And Prevention; 2022 Jan 20 [accessed 2023 Mar 31]. https://www.cdc.gov/shingles/vaccination/immunocompromised-adults.html.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy. Hum Vaccin Immunother. 2013;9(8):1763–1773. doi:10.4161/hv.24657.
  • Zheng H, Jiang S, Wu Q. Factors influencing COVID-19 vaccination intention: the roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication. Patient Educ Couns. 2022;105(2):277–283. doi:10.1016/j.pec.2021.09.023.
  • Kantar, LifePoints. Kantar; 2023 Nov 23 [accessed 2023 Nov 23]. https://www.kantar.com/campaigns/pf/lifepoints.
  • Akakura K, Bolton D, Grillo V, Mermod N. Not all prostate cancer is the same – patient perceptions: an Asia-Pacific region study. BJU Int. 2020;126 (S1):38–45. doi:10.1111/bju.15129.
  • Ferrante JM, Fyffe DC, Vega ML, Piasecki AK, Ohman-Strickland PA, Crabtree BF. Family physicians’ barriers to cancer screening in extremely obese patients. Obesity (Silver Spring). 2010;18(6):1153–9. doi:10.1038/oby.2009.481.
  • McMullen S, Hess LM, Kim ES, Levy B, Mohamed M, Waterhouse D, Wozniak A, Goring S, Müller K, Muehlenbein C, et al. Treatment decisions for advanced non-squamous non-small cell lung cancer: patient and physician perspectives on maintenance therapy. Patient. 2019;12(2):223–233. doi:10.1007/s40271-018-0327-3.
  • Guest G, Namey E, Chen M, Soundy A. A simple method to assess and report thematic saturation in qualitative research. PLos One. 2020;15(5):e0232076. doi:10.1371/journal.pone.0232076.
  • Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi:10.1186/1748-5908-6-42.
  • Gleneagles Hospital. New generation shingles vaccination (Gleneagles Medical Clinic Central). Gleneagles Hospital; 2022 Nov 16 [accessed 2022 Nov 16]. https://gleneagles.hk/promotions/new-generation-shingles-vaccination-gleneagles-medical-clinic-central.
  • Marina Medical. Shingles (also known as “Herpes zoster”) vaccination. Marina Medical; 2022 Nov 16 [accessed 2022 Nov 16]. https://marinamedical.hk/en/services/vaccination/shingles-vaccination.
  • Centre for Health Protection. Chicken Pox. Department of health, the government of the Hong Kong special administrative region; 2019 Jul 5 [accessed 2022 Nov 16]. https://www.chp.gov.hk/en/healthtopics/content/24/15.html.
  • Cheong K. 1 in 5 shingles patients had pain for more than a month; illness can cost more than $300. The Straits Times; 2014 Jun 16 [accessed 2022 Nov 16]. https://www.straitstimes.com/singapore/health/1-in-5-shingles-patients-had-pain-for-more-than-a-month-illness-can-cost-more-than.
  • Chew J. 5 things to know about shingles. The Straits Times; 2022 Feb 18 [accessed 2022 Nov 16]. https://www.straitstimes.com/singapore/health/5-things-to-know-about-shingles.
  • Health Hub. Herpes zoster (shingles). 2023 Sep 15 [accessed 2023 Nov 2]. https://www.healthhub.sg/a-z/diseases-and-conditions/141/herpes_zoster.
  • Narae Medical Foundation. Shingles vaccination price and recommended target (should people who have already had shingles also get vaccinated) [Translated from Korean]. Narae Medical Center; 2021 Oct 3 [accessed 2022 Nov 16]. https://blog.naver.com/naraemedical01/222270561792.
  • Chen C-C, Chung J. Shingles affecting young people more often: doctor. Taipei Times; 2019 Jan 1 [accessed 2022 Nov 16]. https://www.taipeitimes.com/News/taiwan/archives/2019/01/01/2003707150.
  • Tri-Service General Hospital. Herpes zoster. Tri-service general hospital; 2023 Feb 11 [accessed 2023 Nov 2]. https://wwwv.tsgh.ndmctsgh.edu.tw/uniten/10016/28899.
  • Paek E, Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology. 2010;56(1):20–31. doi:10.1159/000240046.
  • Lam AC, Chan MY, Chou HY, Ho SY, Li HL, Lo CY, Shek KF, To SY, Yam KK, Yeung I. A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J. 2017;23(4):365–73. doi:10.12809/hkmj165043.
  • Al-Khalidi T, Genidy R, Almutawa M, Mustafa M, Adra S, Kanawati NE, Binashour T, Barqawi HJ. Knowledge, attitudes, and practices of the United Arab Emirates population towards herpes zoster vaccination: a cross-sectional study. Hum Vaccin Immunother. 2022;18(5):2073752. doi:10.1080/21645515.2022.2073752.
  • Tsui E, Gillespie C, Perskin M, Zabar S, Wu M, Cohen EJ. Evaluating physician attitudes and practices regarding herpes zoster vaccination. Cornea. 2018;37(8):947–51. doi:10.1097/ico.0000000000001582.
  • Valente N, Lupi S, Stefanati A, Cova M, Sulcaj N, Piccinni L, Gabutti G. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study. BMJ Open. 2016;6(10):e011539. doi:10.1136/bmjopen-2016-011539.
  • Baalbaki NA, Fava JP, Ng M, Okorafor E, Nawaz A, Chiu W, Salim A, Cha R, Kilgore PE. A community-based survey to assess knowledge, attitudes, beliefs and practices regarding herpes zoster in an urban setting. Infect Dis Ther. 2019;8(4):687–94. doi:10.1007/s40121-019-00269-2.
  • Casigliani V, Menicagli D, Fornili M, Lippi V, Chinelli A, Stacchini L, Arzilli G, Scardina G, Baglietto L, Lopalco P, et al. Vaccine hesitancy and cognitive biases: evidence for tailored communication with parents. Vaccine. 2022;11:100191. doi:10.1016/j.jvacx.2022.100191.
  • Azarpanah H, Farhadloo M, Vahidov R, Pilote L. Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health. 2021;21(1):1686. doi:10.1186/s12889-021-11745-1.
  • Xu G, Xu S, Gong W, Dong S, Yu H. Low trend for VZV-Associated disease patients to visit neurologists. J Multidiscip Healthc. 2023;16:1379–1392. doi:10.2147/JMDH.S412398.